Found: 4
Select item for more details and to access through your institution.
Apixaban and rivaroxaban use for atrial fibrillation in patients with obesity and BMI ≥50 kg/m<sup>2</sup>.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 2, p. 112, doi. 10.1002/phar.2651
- By:
- Publication type:
- Article
Atrial Fibrillation Management: A Comprehensive Review with a Focus on Pharmacotherapy, Rate, and Rhythm Control Strategies.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 5, p. 475, doi. 10.1007/s40256-022-00529-6
- By:
- Publication type:
- Article
Prediction of heart failure and all-cause mortality using cardiac ultrasomics in patients with breast cancer.
- Published in:
- International Journal of Cardiovascular Imaging, 2024, v. 40, n. 6, p. 1305, doi. 10.1007/s10554-024-03101-2
- By:
- Publication type:
- Article
Pre-existing cardiovascular disease increases risk of atrial arrhythmia and mortality in cancer patients treated with Ibrutinib.
- Published in:
- Cardio-Oncology, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40959-021-00125-8
- By:
- Publication type:
- Article